 |
Code of Federal Regulations (Last Updated: October 10, 2024) |
 |
Title 21 - Food and Drugs |
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
SubChapter H - Medical Devices |
|
Part 862 - Clinical Chemistry and Clinical Toxicology Devices |
|
Subpart B - Clinical Chemistry Test Systems |
§ 862.1117 - B-type natriuretic peptide test system.
Latest version.
-
§ 862.1117 B-type natriuretic peptide test system.
(a) Identification. The B-type natriuretic peptide (BNP) test system is an in vitro diagnostic device intended to measure BNP in whole blood and plasma. Measurements of BNP are used as an aid in the diagnosis of patients with congestive heart failure.
(b) Classification. Class II (special controls). The special control is “Class II Special Control Guidance Document for B-Type Natriuretic Peptide Premarket Notifications; Final Guidance for Industry and FDA Reviewers.”
[66 FR 12734, Feb. 28, 2001]